Header Logo

Connection

Kern Singh to Minimally Invasive Surgical Procedures

This is a "connection" page, showing publications Kern Singh has written about Minimally Invasive Surgical Procedures.
  1. Postoperative clinical outcomes in patients undergoing MIS-TLIF versus LLIF for adjacent segment disease. Acta Neurochir (Wien). 2023 07; 165(7):1907-1914.
    View in: PubMed
    Score: 0.684
  2. Single-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion versus Anterior Lumbar Interbody Fusion with Posterior Instrumentation at L5/S1. World Neurosurg. 2022 01; 157:e111-e122.
    View in: PubMed
    Score: 0.609
  3. Validation of VR-12 Physical Function in Minimally Invasive Lumbar Discectomy. World Neurosurg. 2021 11; 155:e362-e368.
    View in: PubMed
    Score: 0.604
  4. Validity of Patient Health Questionnaire-9 in Minimally Invasive Lumbar Interbody Fusion. Spine (Phila Pa 1976). 2020 Jun 01; 45(11):E663-E669.
    View in: PubMed
    Score: 0.555
  5. Complications Following Minimally Invasive Transforaminal Lumbar Interbody Fusion: Incidence, Independent Risk Factors, and Clinical Impact. Clin Spine Surg. 2020 06; 33(5):E236-E240.
    View in: PubMed
    Score: 0.555
  6. PHQ-9 Score Predicts Postoperative Outcomes Following Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2019 12; 32(10):444-448.
    View in: PubMed
    Score: 0.536
  7. Patient Perceptions of Iliac Crest Bone Grafting in Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2019 12; 32(10):430-434.
    View in: PubMed
    Score: 0.536
  8. The Impact of Comorbidity Burden on Complications, Length of Stay, and Direct Hospital Costs After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Spine (Phila Pa 1976). 2019 03 01; 44(5):363-368.
    View in: PubMed
    Score: 0.509
  9. The Effect of Preoperative Medications on Length of Stay, Inpatient Pain, and Narcotics Consumption After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2019 02; 32(1):E37-E42.
    View in: PubMed
    Score: 0.506
  10. Iliac Crest Bone Graft for Minimally Invasive Transforaminal Lumbar Interbody Fusion: A Prospective Analysis of Inpatient Pain, Narcotics Consumption, and Costs. Spine (Phila Pa 1976). 2018 09 15; 43(18):1307-1312.
    View in: PubMed
    Score: 0.493
  11. Validity of PROMIS in minimally invasive transforaminal lumbar interbody fusion: a preliminary evaluation. J Neurosurg Spine. 2018 07; 29(1):28-33.
    View in: PubMed
    Score: 0.479
  12. Patient Perceptions of Minimally Invasive Versus Open Spine Surgery. Clin Spine Surg. 2018 04; 31(3):E184-E192.
    View in: PubMed
    Score: 0.478
  13. Is Body Mass Index a Risk Factor for Revision Procedures After Minimally Invasive Transforaminal Lumbar Interbody Fusion? Clin Spine Surg. 2018 02; 31(1):E85-E91.
    View in: PubMed
    Score: 0.473
  14. The Utility of Routinely Obtaining Postoperative Laboratory Studies Following a Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2017 Dec; 30(10):E1405-E1410.
    View in: PubMed
    Score: 0.467
  15. Multimodal Analgesia Versus Intravenous Patient-Controlled Analgesia for Minimally Invasive Transforaminal Lumbar Interbody Fusion Procedures. Spine (Phila Pa 1976). 2017 Aug 01; 42(15):1145-1150.
    View in: PubMed
    Score: 0.456
  16. Minimally invasive lumbar decompression-the surgical learning curve. Spine J. 2016 08; 16(8):909-16.
    View in: PubMed
    Score: 0.397
  17. Minimally Invasive Transforaminal Lumbar Interbody Fusion. J Spinal Disord Tech. 2015 Jul; 28(6):222-5.
    View in: PubMed
    Score: 0.395
  18. BMP-2-induced Neuroforaminal Bone Growth in the Setting of a Minimally Invasive Transforaminal Lumbar Interbody Fusion. J Spinal Disord Tech. 2015 Jun; 28(5):186-8.
    View in: PubMed
    Score: 0.393
  19. Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion. Spine (Phila Pa 1976). 2014 Feb 01; 39(3):185-91.
    View in: PubMed
    Score: 0.358
  20. Minimum Clinically Important Difference in Patients Undergoing Minimally Invasive Transforaminal Lumbar Interbody Fusion. Neurosurgery. 2023 06 01; 92(6):1199-1207.
    View in: PubMed
    Score: 0.166
  21. Impact of Ambulatory Setting for Workers' Compensation Patients Undergoing One-Level Minimally Invasive Transforaminal Lumbar Interbody Fusion and Review of the Literature. World Neurosurg. 2022 Nov; 167:e251-e267.
    View in: PubMed
    Score: 0.162
  22. Comparing Patient-Reported Outcomes in Patients Undergoing Lumbar Fusion for Isthmic Spondylolisthesis with Predominant Back Pain versus Predominant Leg Pain Symptoms. World Neurosurg. 2022 Oct; 166:e672-e680.
    View in: PubMed
    Score: 0.161
  23. Lateral Lumbar Interbody Fusion: Single Surgeon Learning Curve. World Neurosurg. 2022 08; 164:e411-e419.
    View in: PubMed
    Score: 0.159
  24. Spine Surgery Complications in the Ambulatory Surgical Center Setting: Systematic Review. Clin Spine Surg. 2022 04 01; 35(3):118-126.
    View in: PubMed
    Score: 0.158
  25. The Effect of the Severity of Preoperative Disability on Patient-Reported Outcomes and Patient Satisfaction Following Minimally Invasive Transforaminal Lumbar Interbody Fusion. World Neurosurg. 2022 Mar; 159:e334-e346.
    View in: PubMed
    Score: 0.155
  26. Impact of Advanced Age on Postoperative Outcomes Following Transforaminal Lumbar Interbody Fusion. J Am Acad Orthop Surg. 2021 Sep 01; 29(17):e869-e879.
    View in: PubMed
    Score: 0.151
  27. Validation of PROMIS Physical Function in MIS TLIF: 2-Year Follow-up. Spine (Phila Pa 1976). 2020 Nov 15; 45(22):E1516-E1522.
    View in: PubMed
    Score: 0.143
  28. Diabetes Does Not Increase Complications, Length of Stay, or Hospital Costs After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2020 08; 33(7):E307-E311.
    View in: PubMed
    Score: 0.140
  29. The Effect of Preoperative Symptom Duration on Postoperative Outcomes After Minimally Invasive Transforaminal Lumbar Interbody Fusion. Clin Spine Surg. 2020 07; 33(6):E263-E268.
    View in: PubMed
    Score: 0.140
  30. The identification of risk factors for increased postoperative pain following minimally invasive transforaminal lumbar interbody fusion. Eur Spine J. 2020 06; 29(6):1304-1310.
    View in: PubMed
    Score: 0.136
  31. The Effect of Preoperative Symptom Duration on Postoperative Outcomes After a Tubular Lumbar Microdiscectomy. Clin Spine Surg. 2019 02; 32(1):E27-E30.
    View in: PubMed
    Score: 0.127
  32. Comparison of Postoperative Outcomes Between Primary MIS TLIF and MIS TLIF With Revision Decompression. Spine (Phila Pa 1976). 2019 Jan 15; 44(2):150-156.
    View in: PubMed
    Score: 0.126
  33. Minimally invasive transforaminal lumbar interbody fusion: one surgeon's learning curve. Spine J. 2014 Aug 01; 14(8):1460-5.
    View in: PubMed
    Score: 0.087
  34. Subaxial cervical and cervicothoracic fixation techniques--indications, techniques, and outcomes. Orthop Clin North Am. 2012 Jan; 43(1):19-28, vii.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.